Camilla Gustafsen

Camilla Gustafsen's work experience starts in 2001 when they worked as an R&D manager at Pipeline Biotech A/S until 2003. Camilla then joined Aarhus Universitet, where they held various roles, including Research Assistant from 2004 to 2005, PhD fellow from 2005 to 2009, Postdoc from 2009 to 2014, and Assistant Professor from 2014 to 2019. In 2014, they also became a Partner at pAbmAbs. From 2017 to 2021, they worked at Draupnir Bio, initially as a Co-Founder and Chief Scientific Officer, and later became the VP Biology. In 2020, they co-founded Muna Therapeutics and served as a Scientific Advisor.

Camilla Gustafsen pursued their education at Aarhus University, starting in 2001 with a focus on Molecular Biology. Camilla obtained a Master of Science degree in this field. Later, they went on to pursue a PhD at the same university, specializing in Medical Biochemistry. It is not specified when they started or completed their PhD program. Additionally, Camilla Gustafsen also has an entry for IMD, but no details are provided regarding the degree or field of study.